A NEW SURGICAL OUTCOME SCORE (SOS) INCLUDING HE4, CA125 AND ASCITES VOLUME CAN PREDICT SURGICAL OUTCOME IN PRIMARY OVARIAN CANCER PATIENTS.

被引：0
|
作者：
Braicu, E. [1 ]
van Gorp, T. [2 ]
Richter, R. [1 ]
Nassir, M. [3 ]
Zeillinger, R. [4 ]
Conicn, N. [5 ]
Tong, D. Cacsire Castillo [4 ]
Mahner, S. [6 ]
Vergote, I. [7 ]
Sehouli, J. [1 ]
机构：
[1] Charite, Dept Gynaecol, D-13353 Berlin, Germany
[2] Univ Hosp Maastricht, Dept Obstet & Gynaecol, Maastricht, Netherlands
[3] Charite Campus Virchow, Dept Gynaecol, Berlin, Germany
[4] Med Univ Vienna, Mol Oncol Grp, Vienna, Austria
[5] Med Univ Innsbruck, Dept Obstet & Gynecol, A-6020 Innsbruck, Austria
[6] Med Univ Hamburg, Clin Gynecol, Hamburg, Germany
[7] Univ Hosp KU Leuven, Dept Obstet & Gynaecol, Louvain, Belgium
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2013年 / 23卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] HE4 and eIF3a Expression Correlates with Surgical Outcome and Overall Survival in Ovarian Cancer Patients with Secondary Cytoreduction
    Luo, Chen-Hui
    Zhao, Min
    Chen, Xiao-Yan
    Shahabi, Shohreh
    Qiang, Wenan
    Zeng, Liang
    Wang, Jing
    Zhou, Hong-Hao
    JOURNAL OF CANCER, 2018, 9 (14): : 2472 - 2479
  • [42] A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
    Moore, Richard G.
    McMeekin, D. Scott
    Brown, Amy K.
    DiSilvestro, Paul
    Miller, M. Craig
    Allard, W. Jeffrey
    Gajewski, Walter
    Kurman, Robert
    Bast, Robert C., Jr.
    Skates, Steven J.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (01) : 40 - 46
  • [43] Prognostic Impact of Prechemotherapy Serum Levels of HER2, CA125, and HE4 in Ovarian Cancer Patients
    Steffensen, Karina Dahl
    Waldstrom, Marianne
    Brandslund, Ivan
    Jakobsen, Anders
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (06) : 1040 - 1047
  • [44] EVALUATION OF THE CLINICAL USEFULNESS OF HE4 AND CA125 ASSAYS IN MONITORING TREATMENT RESPONSE OF PATIENTS WITH ADVANCED OVARIAN CANCER
    Kotowicz, B.
    Fuksiewicz, M.
    Berezowska, A.
    Jalinik, K.
    Bidzinski, M.
    Kowalska, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A483 - A484
  • [45] Ca125, HE4 and systemic immune inflammation index during maintenance with PARPi in ovarian cancer patients: three markers, two markers, or usual ca125?
    Piovano, Elisa
    Borella, Fulvio
    Chiparo, Maria Pia
    Casetta, Elena
    Laudani, Maria Elena
    Fucina, Stefano
    Seminara, Ylenia
    Grimaudo, Ida
    Danese, Saverio
    Picardo, Elisa
    Katsaros, Dionyssios
    Revelli, Alberto
    Cosma, Stefano
    Zola, Paolo
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A344 - A345
  • [46] Evaluation of serum CA125, HE4 and CA724 and the risk of ovarian malignancy algorithm score in the diagnosis of high-grade serous ovarian cancer
    Hu, Deyu
    Qian, Jun
    Yin, Fenghua
    Wei, Bing
    Wang, Jiayu
    Zhang, Huijuan
    Yang, Haiou
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2024, 297 : 170 - 175
  • [47] THE DIAGNOSTIC VALUE OF ADDING HE4 TO CA125 FOR WOMEN INVESTIGATED FOR OVARIAN CANCER IN PRIMARY CARE: A PROSPECTIVE PILOT STUDY.
    Ratnavelu, N.
    Founta, C.
    Addison, C.
    Bradbury, M.
    Handley, G.
    Das, M.
    Kucukmetin, A.
    Naik, R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 18 - 19
  • [48] An ovarian cancer malignancy risk index composed of HE4, CA125, ultrasonographic score, and menopausal status: use in differentiation of ovarian cancers and benign lesions
    Macuks, Ronalds
    Baidekalna, Ieva
    Donina, Simona
    TUMOR BIOLOGY, 2012, 33 (05) : 1811 - 1817
  • [49] Diagnostic performances of HE4 and CA125 for the detection of ovarian cancer from patients with various gynecologic and non-gynecologic diseases
    Park, Yongjung
    Lee, Jong-Han
    Hong, Duck Jin
    Lee, Eun Young
    Kim, Hyon-Suk
    CLINICAL BIOCHEMISTRY, 2011, 44 (10-11) : 884 - 888
  • [50] Serum CA125 levels predict outcome of interval debulking surgery after neoadjuvant chemotherapy in patients with advanced ovarian cancer
    Zhang, Dan
    Jiang, Yu-xia
    Luo, Shu-juan
    Zhou, Rong
    Jiang, Qing-xiu
    Linghu, Hua
    CLINICA CHIMICA ACTA, 2018, 484 : 32 - 35
12345